In line with the histological analysis, results from the mRNA expression of pro-fibrotic genes (including Acta2, Col1a1, Col1a2, and Tgfb1) further demonstrated that prophylactic but not therapeutic administration of OCA were effective against liver fibrosis (Fig. 1d). The gene discussed is COL1A1; the disease is Hepatic fibrosis.